Quality of life, efficacy, and patient-reported outcome with NEPA as antiemetic prophylaxis in patients receiving highly or moderately emetogenic chemotherapy

被引：0
|
作者：
Karthaus, M. [1 ]
Rauh, J. [1 ]
Guth, D. [1 ]
Heilmann, V. [1 ]
Schilling, J. [1 ]
机构：
[1] Stadt Klinikum Munchen Harlaching, Klin Hamatol Onkol & Palliat Med, Munich, Germany
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1506TiP
引用
收藏
页数：1
相关论文
共 50 条
  • [41] An analysis of the antiemetic protection of metoclopramide plus dexamethasone in Chinese patients receiving moderately high emetogenic chemotherapy
    Molassiotis, A
    Mok, TSK
    Yam, BMC
    Yung, H
    EUROPEAN JOURNAL OF CANCER CARE, 2002, 11 (02) : 108 - 113
  • [42] Ondansetron plus metopimazine compared with ondansetron plus metopimazine plus prednisolone as antiemetic prophylaxis in patients receiving multiple cycles of moderately emetogenic chemotherapy
    Sigsgaard, T
    Herrstedt, J
    Handberg, J
    Kjær, M
    Dombernowsky, P
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (07) : 2091 - 2097
  • [43] Efficacy of antiemetic regimens for prevention and treatment of chemotherapy-induced nausea and vomiting in patients of breast cancer receiving highly emetogenic chemotherapy
    Vij, Soumya
    Dhasmana, Dilip Chander
    Bala, Suman
    Verma, Sanjiv Kumar
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (06) : 819 - 824
  • [44] Health outcomes and cost-effectiveness of aprepitant in outpatients receiving antiemetic prophylaxis for highly emetogenic chemotherapy in Germany
    Lordick, Florian
    Ehlken, Birgit
    Ihbe-Heffinger, Angela
    Berger, Karin
    Krobot, Karl J.
    Pellissier, James
    Davies, Glenn
    Deuson, Robert
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (02) : 299 - 307
  • [45] Ten year trends in antiemetic prescribing in cancer patients receiving highly emetogenic chemotherapy (HEC)
    O'Sullivan, Ciara C.
    Van Houten, Holly K.
    Sangaralingham, Lindsey
    Leal, Alexis D.
    Shinde, Shivani
    Liu, Hongfang
    Ettinger, David
    Loprinzi, Charles L.
    Ruddy, Kathryn J.
    CANCER RESEARCH, 2018, 78 (04)
  • [46] ASSOCIATION OF ABC POLYMORPHISM WITH ANTIEMETIC EFFICACY IN CANCER PATIENTS TREATED WITH HIGHLY EMETOGENIC CHEMOTHERAPY
    Tsuji, Daiki
    Kim, Yong-Il
    Daimon, Takashi
    Makuta, Ryo
    Homma, Chiho
    Nakamichi, Hidenori
    Yamamoto, Keisuke
    Hayashi, Hideki
    Inoue, Kazuyuki
    Itoh, Kunihiko
    ANNALS OF ONCOLOGY, 2014, 25
  • [47] Early Austrian multicenter experience with palonosetron as antiemetic treatment for patients undergoing highly or moderately emetogenic chemotherapy
    Petru E.
    Andel J.
    Angleitner-Boubenizek L.
    Steger G.
    Bernhart M.
    Busch K.
    Gehmacher O.
    Hernler T.
    Kastner U.
    Lanz-Veit A.
    Pluschnigg U.
    Polachova J.
    Rohde M.
    Schiller L.
    Schramböck R.
    Stangl W.
    Thödtmann R.
    Zabernigg A.
    Wiener Medizinische Wochenschrift, 2008, 158 (5-6) : 169 - 173
  • [48] Safety and efficacy of a continuous infusion, patient-controlled antiemetic pump for children receiving emetogenic chemotherapy
    Jones, Emma
    Koyama, Tatsuki
    Ho, Richard H.
    Kuttesch, John
    Shankar, Sadhna
    Whitlock, James A.
    Cartwright, Julia
    Frangoul, Haydar
    PEDIATRIC BLOOD & CANCER, 2007, 48 (03) : 330 - 332
  • [49] Efficacy of Aprepitant in Patients with Advanced or Recurrent Lung Cancer Receiving Moderately Emetogenic Chemotherapy
    Uchino, Junji
    Hirano, Ryosuke
    Tashiro, Naoki
    Yoshida, Yuji
    Ushijima, Shinichiro
    Matsumoto, Takemasa
    Ohta, Keiichi
    Nakatomi, Keita
    Takayama, Koichi
    Fujita, Masaki
    Nakanishi, Yoichi
    Watanabe, Kentaro
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (08) : 4187 - 4190
  • [50] Prolonged usage of NEPA for prevention of long-delayed CINV in patients receiving highly emetogenic chemotherapy
    Xu, L.
    Sun, Y.
    Meng, F.
    Liu, C.
    Guan, S.
    Zhong, D.
    Zhang, L.
    ANNALS OF ONCOLOGY, 2024, 35 : S1599 - S1599
12345